As of 2024-12-13, the Relative Valuation of Chromadex Corp (CDXC) is 0.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.38 USD, the upside of Chromadex Corp based on Relative Valuation is -90.2%.
The range of the Relative Valuation is 0.43 - 0.92 USD.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 47.6x | 37.6x |
| Forward P/E multiples | 21.9x - 32.8x | 26.4x |
| Fair Price | 0.43 - 0.92 | 0.62 |
| Upside | -93.3% - -85.5% | -90.2% |
| Date | P/E |
| 2024-12-11 | 331.75 |
| 2024-12-10 | 345.12 |
| 2024-12-09 | 339.47 |
| 2024-12-06 | 345.64 |
| 2024-12-05 | 342.55 |
| 2024-12-04 | 387.30 |
| 2024-12-03 | 391.42 |
| 2024-12-02 | 388.84 |
| 2024-11-29 | 397.07 |
| 2024-11-27 | 392.96 |
| 2024-11-26 | 390.39 |
| 2024-11-25 | 383.70 |
| 2024-11-22 | 382.67 |
| 2024-11-21 | 392.44 |
| 2024-11-20 | 385.76 |
| 2024-11-19 | 386.79 |
| 2024-11-18 | 373.93 |
| 2024-11-15 | 350.78 |
| 2024-11-14 | 370.33 |
| 2024-11-13 | 360.55 |
| 2024-11-12 | 372.90 |
| 2024-11-11 | 360.55 |
| 2024-11-08 | 334.32 |
| 2024-11-07 | 348.21 |
| 2024-11-06 | 359.53 |
| 2024-11-05 | 314.26 |
| 2024-11-04 | 295.23 |
| 2024-11-01 | 301.41 |
| 2024-10-31 | 179.51 |
| 2024-10-30 | 184.13 |
| 2024-10-29 | 186.19 |
| 2024-10-28 | 188.76 |
| 2024-10-25 | 178.48 |
| 2024-10-24 | 176.42 |
| 2024-10-23 | 177.96 |
| 2024-10-22 | 179.51 |
| 2024-10-21 | 177.96 |
| 2024-10-18 | 180.02 |
| 2024-10-17 | 176.93 |
| 2024-10-16 | 183.11 |
| 2024-10-15 | 172.31 |
| 2024-10-14 | 175.39 |
| 2024-10-11 | 182.59 |
| 2024-10-10 | 176.93 |
| 2024-10-09 | 167.16 |
| 2024-10-08 | 168.19 |
| 2024-10-07 | 170.76 |
| 2024-10-04 | 173.85 |
| 2024-10-03 | 178.48 |
| 2024-10-02 | 178.48 |